Discovery and Characterization of Spike N‐Terminal Domain‐Binding Aptamers for Rapid SARS‐CoV‐2 Detection

The coronavirus disease 2019 (COVID‐19) pandemic has devastated families and disrupted healthcare, economies and societies across the globe. Molecular recognition agents that are specific for distinct viral proteins are critical components for rapid diagnostics and targeted therapeutics. In this wor...

Full description

Saved in:
Bibliographic Details
Published in:Angewandte Chemie International Edition Vol. 60; no. 39; pp. 21211 - 21215
Main Authors: Kacherovsky, Nataly, Yang, Lucy F., Dang, Ha V., Cheng, Emmeline L., Cardle, Ian I., Walls, Alexandra C., McCallum, Matthew, Sellers, Drew L., DiMaio, Frank, Salipante, Stephen J., Corti, Davide, Veesler, David, Pun, Suzie H.
Format: Journal Article
Language:English
Published: Germany Wiley Subscription Services, Inc 20-09-2021
John Wiley and Sons Inc
Edition:International ed. in English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The coronavirus disease 2019 (COVID‐19) pandemic has devastated families and disrupted healthcare, economies and societies across the globe. Molecular recognition agents that are specific for distinct viral proteins are critical components for rapid diagnostics and targeted therapeutics. In this work, we demonstrate the selection of novel DNA aptamers that bind to the SARS‐CoV‐2 spike glycoprotein with high specificity and affinity (<80 nM). Through binding assays and high resolution cryo‐EM, we demonstrate that SNAP1 (SARS‐CoV‐2 spike protein N‐terminal domain‐binding aptamer 1) binds to the S N‐terminal domain. We applied SNAP1 in lateral flow assays (LFAs) and ELISAs to detect UV‐inactivated SARS‐CoV‐2 at concentrations as low as 5×105 copies mL−1. SNAP1 is therefore a promising molecular tool for SARS‐CoV‐2 diagnostics. Rapid diagnostics are essential for early detection of COVID‐19 and reduced disease spread. In this study, we discovered the DNA aptamer SNAP1 (SARS‐CoV‐2 spike protein N‐terminal domain binding aptamer 1), which binds with high affinity and specificity to SARS‐CoV‐2 spike protein as well as UV‐inactivated SARS‐CoV‐2 virus.
Bibliography:These authors contributed equally to this work.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1433-7851
1521-3773
1521-3773
DOI:10.1002/anie.202107730